Heritage Pharmaceuticals Inc voluntarily recalled Clindamycin Palmitate Oral Solution on July 30, 2026, after the FDA announced the presence of foreign particles and white flakes in reconstituted bottles. The Food and Drug Administration issued the recall notice for the Class II violation.
How to tell if you have it
- Brand: Heritage Pharmaceuticals
- Product: Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75 mg/5 mL, Rx Only, 100 mL
- Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816
- NDC: 23155-603-51
- Lot #: 2411550
- Expiration: 2026/NOV
The hazard
The recall addresses the presence of particles and white flakes in the reconstituted bottles. The FDA classified this as a Class II recall due to the foreign substance risk.
Context
GovInfoNow's records show Heritage Pharmaceuticals Inc has 11 other recalls on record since 2015-02-25. Other recent recalls include a 2025-10-06 Desipramine Tablets recall for N-Nitroso Impurity Risk, a 2022-11-23 Desmopressin Tablets recall for Subpotent Drug Risk, and a 2021-04-21 Acyclovir Tablets recall for Missing Lot/Exp Date. Other recent recalls of similar products include SUN PHARMACEUTICAL Clindamycin Phosphate Topical Solution Recall (2025-11-26) and Baxter Clindamycin Injection Recalls (2026-08-06).